Giefer Matthew J, Kozarek Richard A
Pediatrics - Gastroenterology, Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA, 98105, USA.
Digestive Disease Institute at Virginia Mason Medical Center, Seattle, WA, 98105, USA.
Surg Endosc. 2015 Dec;29(12):3543-50. doi: 10.1007/s00464-015-4105-1. Epub 2015 Feb 12.
Previous reports have suggested that endoscopic retrograde cholangiopancreatography (ERCP) in pediatric patients is safe, but because the total number of cases reported in the literature remains small, questions remain regarding safety and outcomes of this procedure in children.
Pediatric patients who underwent ERCP were identified from diagnostic to billing codes. Medical records were examined for age, gender, diagnosis codes, indication, type of sedation, findings, interventions, and complications. Descriptive statistics were prepared for data including frequencies, percentages for categorical variables, and means and standard deviations for quantitative variables. Extensions of logistic regression were used to examine the relationship between demographic and clinical characteristics and post-ERCP pancreatitis.
Four hundred and twenty-five ERCPs were performed on 276 pediatric patients. Patient's age ranged from 72 days to 18 years, and there was equal gender distribution. Targeted duct cannulation was achieved in over 95% of cases, and therapeutic interventions were common (81.3%). The most common indications were biliary obstruction (43.3%) and chronic pancreatitis (26.8%). The most common complication was post-ERCP pancreatitis which occurred in 26 cases (7.7%), and the majority was mild by consensus definition. Procedural characteristics significantly associated with post-ERCP pancreatitis included: pancreatogram, pancreatic sphincterotomy, pancreatic duct stenting, and pancreatic duct stricture dilation. Immediate post-sphincterotomy bleeding occurred twice (1.1%), and both cases were successfully treated during the procedure. There was one instance of a possible delayed sphincterotomy bleed. No mortality was observed.
This retrospective review is one of the larger ERCP series reported in the pediatric population and adds to the growing body of literature supporting that ERCP can be safely applied in younger patients by skilled endoscopists. The complication rate found in this series closely parallels that observed in adults. Prospective studies of pediatric ERCP are still required to more definitively define the safe and appropriate use of this procedure in children.
既往报告提示,儿科患者的内镜逆行胰胆管造影术(ERCP)是安全的,但由于文献中报道的病例总数仍然较少,该手术在儿童中的安全性和结局仍存在疑问。
通过诊断和计费代码识别接受ERCP的儿科患者。检查病历以获取年龄、性别、诊断代码、适应证、镇静类型、检查结果、干预措施和并发症。对数据进行描述性统计,包括频率、分类变量的百分比以及定量变量的均值和标准差。使用逻辑回归扩展来研究人口统计学和临床特征与ERCP术后胰腺炎之间的关系。
对276例儿科患者进行了425次ERCP。患者年龄从72天至18岁不等,性别分布均衡。超过95%的病例实现了目标胆管插管,治疗性干预很常见(81.3%)。最常见的适应证是胆道梗阻(43.3%)和慢性胰腺炎(26.8%)。最常见的并发症是ERCP术后胰腺炎,发生26例(7.7%),根据共识定义,大多数为轻度。与ERCP术后胰腺炎显著相关的操作特征包括:胰管造影、胰括约肌切开术、胰管支架置入和胰管狭窄扩张。括约肌切开术后立即出血发生2次(1.1%),两例均在手术过程中成功治疗。有1例可能的括约肌切开术延迟出血。未观察到死亡病例。
这项回顾性研究是儿科人群中报道的较大规模ERCP系列研究之一,为越来越多支持ERCP可由技术熟练的内镜医师安全应用于较年轻患者的文献增添了内容。本系列研究中发现的并发症发生率与成人中观察到的情况相近。仍需要对儿科ERCP进行前瞻性研究,以更明确地界定该手术在儿童中的安全和适当应用。